Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 2g
Tazobactam 250mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Wyeth Lederle SrL, Catania, Italy
Product: Tazocin EF
Active Ingredients: Piperacillin monohydrate 4g
Tazobactam 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Lederle SrL, Catania, Italy
Pfizer Biotech Corporation, Hsinfeng Hsiang Hsinchu Hsien, Taiwan
Dated this 19th day of September 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).